» Articles » PMID: 18177225

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

Citing Articles

Optimizing ICU antifungal therapy: overcoming pharmacokinetic limitations with combination strategies.

Liao R, Zheng X Intensive Care Med. 2025; .

PMID: 40063256 DOI: 10.1007/s00134-025-07846-9.


1-methylnicotinamide modulates IL-10 secretion and voriconazole metabolism.

Deng X, Li Y, Jiang L, Xie X, Wang X Front Immunol. 2025; 16:1529660.

PMID: 40018042 PMC: 11865947. DOI: 10.3389/fimmu.2025.1529660.


Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by After the Introduction of Anti-Mold Azole Agents: A 30-Year Study at a Tertiary Cancer Center.

Hachem R, Dagher H, Chaftari A, Jiang Y, Haddad A, Wehbe S J Fungi (Basel). 2025; 11(2).

PMID: 39997413 PMC: 11856670. DOI: 10.3390/jof11020119.


Bjerkandera adusta Fungi as Causative Agent of Invasive Chronic Rhinosinusitis.

Kurata Y, Kimizuka Y, Yaguchi T, Ito K, Yamamoto T, Serizawa Y Emerg Infect Dis. 2025; 31(2):355-358.

PMID: 39983679 PMC: 11845138. DOI: 10.3201/eid3102.241275.


A PCR-Based Approach for Early Diagnosis of Head and Neck Aspergillosis: A Pilot Study.

Gomes T, Bastos V, Boniek D, Romanach M, Rocha F, Chaves R Genes (Basel). 2024; 15(11).

PMID: 39596628 PMC: 11594221. DOI: 10.3390/genes15111428.